Skip to main content
4DMEDICAL LIMITED logo

4DMEDICAL LIMITED — Investor Relations & Filings

Ticker · 4DX ISIN · AU0000095416 LEI · 9845000A8F12A6A6FD75 ASX Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 546 across all filing types
Latest filing 2023-10-25 Share Issue/Capital Cha…
Country AU Australia
Listing ASX 4DX

About 4DMEDICAL LIMITED

https://4dmedical.com/

4DMedical Limited develops non-invasive respiratory imaging solutions centered on its proprietary XV Technology. This platform utilizes advanced algorithms to transform standard X-ray sequences into four-dimensional quantitative data, visualizing regional lung function in motion. The flagship XV Lung Ventilation Analysis Software (XV LVAS) provides clinicians with detailed maps of airflow distribution throughout the respiratory cycle, facilitating the early detection and monitoring of chronic conditions such as COPD, asthma, and interstitial lung disease. By providing objective, high-resolution insights into lung ventilation without the limitations of traditional pulmonary function tests, the company's cloud-based diagnostic tools aim to improve clinical workflows and patient management. The integration of artificial intelligence further enhances its capability to deliver precise, automated lung tissue analysis.

Recent filings

Filing Released Lang Actions
Application for quotation of securities - 4DX 9 pages 32.0KB
Share Issue/Capital Change Classification · 100% confidence The document is an application for quotation of securities issued under an employee incentive scheme by 4DMedical Limited. It details the number and type of securities to be quoted, issue dates, and compliance with ASX Listing Rules. There is no financial performance data, earnings information, or management discussion. The document is a regulatory announcement related to capital markets and securities listing rather than a financial report or management report. This fits the category of Share Issue/Capital Change (SHA), as it concerns the issuance and quotation of new shares under an employee incentive plan.
2023-10-25 English
Application for quotation of securities - 4DX 9 pages 32.0KB
Capital/Financing Update Classification · 95% confidence The document is an application for quotation of securities issued under an employee incentive scheme by 4DMedical Limited. It details the number and type of securities to be quoted, issue dates, and compliance with ASX Listing Rules. There is no financial performance data, earnings information, or management discussion. The document is a regulatory announcement related to capital markets and securities listing rather than a financial report or earnings release. It fits best under the category of Capital/Financing Update (CAP) as it concerns issuance and quotation of new securities.
2023-10-19 English
Application for quotation of securities - 4DX 10 pages 35.3KB
Share Issue/Capital Change Classification · 100% confidence The document is an application for quotation of securities issued under an employee incentive scheme by 4DMedical Limited. It details the number and types of securities to be quoted, issue dates, and considerations for the securities issued. The document is a formal announcement related to the listing of new securities on the ASX, not a financial report or earnings release. It does not contain financial statements or management discussion but focuses on the issuance and quotation of shares. This fits the category of Share Issue/Capital Change (SHA), which covers announcements regarding new share issues or capital changes.
2023-10-10 English
Notification regarding unquoted securities - 4DX 9 pages 34.0KB
Share Issue/Capital Change Classification · 100% confidence The document is a detailed notification regarding the issue, conversion, or payment up of unquoted equity securities by 4DMedical Limited. It includes specifics about the types and numbers of securities issued, dates of issuance, details about securities issued to key management personnel, and references to the company's Long Term Incentive Plan. The document is structured as a formal announcement to the ASX (Australian Securities Exchange) about securities issuance under employee incentive schemes and options. There is no indication of financial statements, audit information, earnings data, or management discussion. The content aligns with announcements about share issues or capital changes, specifically unquoted securities issued under employee incentive plans. Therefore, the document fits the category of Share Issue/Capital Change (SHA). The document length (8996 characters) and detailed issuance data confirm it is the announcement itself, not a brief notice or a report publication announcement.
2023-10-03 English
Notification of cessation of securities - 4DX 5 pages 25.2KB
Share Issue/Capital Change Classification · 95% confidence The document is titled 'Notification of cessation of +securities' and details the lapse of certain options (securities) for 4DMedical Limited. It provides specific information about the securities that have ceased, the reason for cessation, and the updated issued capital following these changes. The document is an announcement about changes in the company's issued securities, specifically the cessation of certain options. It does not contain financial statements, management discussion, or detailed financial data. It is not a report but an announcement related to capital changes, specifically the cessation of securities. Therefore, the most appropriate classification is 'Share Issue/Capital Change' (SHA). The document length is 4446 characters, which is consistent with an announcement rather than a full report.
2023-10-03 English
Appointment and retirement of Chair 2 pages 217.2KB
Board/Management Information Classification · 100% confidence The document is an ASX announcement dated 3 October 2023 regarding the retirement of the current Chair and non-executive director Bruce Rathie and the appointment of a new Chair, Lil Bianchi. It discusses changes in the company's board of directors and mentions the withdrawal of an item from the Notice of Annual General Meeting related to the re-election of the retiring director. There is no financial data, earnings information, or detailed report content. The focus is solely on board and management changes. Therefore, this document fits the category of Board/Management Information (MANG). The document length is 4774 characters, which is consistent with a typical announcement rather than a full report.
2023-10-02 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.